Abstract
Background: Coronavirus, called as, “the worst public health crisis for a generation,” is a malevolent silent killer.
Objective: One of the main concerns is containing the disease and avoiding the second wave of the pandemic, likely to arise because of the symptomatic patients, while ensuring the safe execution of day to day tasks.
Methods: The indirect transmission of coronavirus from asymptomatic individuals during incubation time and the identification of the people who have accidentally and unknowingly come in contact with infected but asymptomatic patients pose a significant challenge to the health care providers.
Results: Herein, for the first time, we have introduced a quantitative index; asymptomatic growth, to indicate whether the COVID-19 community spread is under control and if economic activities can be resumed.
Conclusion: More importantly, our system provides a feasible mechanism for improving the index to a level <1, a safety level at which normal economic activities can be conducted.
Keywords: COVID, asymptomatic, spread, corona, growth, asymptomatic growth.
Coronaviruses
Title:Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread
Volume: 2 Issue: 1
Author(s): Keith Lau*
Affiliation:
- iBonus Limited Unit 338, Building 16W Hong Kong Science Park, Shatin 8N.T.,Hong Kong
Keywords: COVID, asymptomatic, spread, corona, growth, asymptomatic growth.
Abstract:
Background: Coronavirus, called as, “the worst public health crisis for a generation,” is a malevolent silent killer.
Objective: One of the main concerns is containing the disease and avoiding the second wave of the pandemic, likely to arise because of the symptomatic patients, while ensuring the safe execution of day to day tasks.
Methods: The indirect transmission of coronavirus from asymptomatic individuals during incubation time and the identification of the people who have accidentally and unknowingly come in contact with infected but asymptomatic patients pose a significant challenge to the health care providers.
Results: Herein, for the first time, we have introduced a quantitative index; asymptomatic growth, to indicate whether the COVID-19 community spread is under control and if economic activities can be resumed.
Conclusion: More importantly, our system provides a feasible mechanism for improving the index to a level <1, a safety level at which normal economic activities can be conducted.
Export Options
About this article
Cite this article as:
Lau Keith *, Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread, Coronaviruses 2021; 2(1) . https://dx.doi.org/10.2174/2666796701999200821160307
DOI https://dx.doi.org/10.2174/2666796701999200821160307 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight
Current Pharmaceutical Biotechnology COVID-19 Epigenetics and Implications for Public Health
Coronaviruses ADR Profile of the Covishield Vaccine Among Healthcare Workers in a Tertiary Care Teaching Hospital in India
Current Drug Safety Therapeutic Options and Treatment Strategies Against COVID-19 in China
Current Organic Synthesis An Updated Review on COVID-19
Infectious Disorders - Drug Targets Deciphering the Flexibility and Dynamics of Geobacillus zalihae Strain T1 Lipase at High Temperatures by Molecular Dynamics Simulation
Protein & Peptide Letters Heteromerization as a Mechanism Modulating the Affinity of the ACE2 Receptor to the Receptor Binding Domain of SARS-CoV-2 Spike Protein
Current Proteomics COVID-19: Pathogenesis and Pharmacological Basis for Use of Passive Antibody Therapy
Current Drug Therapy Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Reviews on Recent Clinical Trials Targeting Natural Products for the Treatment of COVID-19 – An Updated Review
Current Pharmaceutical Design Antibiotic Potentiation of Natural Products: A Promising Target to Fight Pathogenic Bacteria
Current Drug Targets Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Current Medicinal Chemistry Isolation and Characterization of a Trypsin-Chymotrypsin Inhibitor from the Seeds of Green Lentil (Lens culinaris)
Protein & Peptide Letters Remdesivir (GS-5734) for COVID-19 Treatment: Past and Recent Updates
Coronaviruses Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools
Coronaviruses Transmission Modes of COVID-19: A Systematic Review
Infectious Disorders - Drug Targets Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence
Current Pharmaceutical Design Important Role of Relaxation Techniques in Immune Functions, Glycemic Control, and Stress in Diabetic Patients with COVID-19: A Review
Current Diabetes Reviews Docking Paradigm in Drug Design
Current Topics in Medicinal Chemistry How to Measure the Similarity Between Protein Ligand-Binding Sites?
Current Computer-Aided Drug Design